[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$ipsey
$CRNX is generating significant buzz with analysts and users excited about Palsonify's potential as a game-changer in endocrine treatments, leading to high social media engagement.
About $ipsey
Social media analysis of the $ipsey topic, likely related to a financial asset or company.
Engagements: XXX #
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXXXX +12,147%
1 Month: XXXXX +11%
1-Year High: XXXXX on 2025-06-20
1-Year Low: X on 2025-07-05
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: XX no change
1 Month: XX -XXXX%
1-Year High: XX on 2025-05-31
1-Year Low: X on 2025-07-27
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $ipsey in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
1 Week: X no change
1 Month: XX +20%
1-Year High: X on 2025-06-21
1-Year Low: X on 2025-04-27
Sentiment: XXX% #
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XX%
1 Month: XXX% no change
1-Year High: XXX% on 2025-05-07
1-Year Low: XX% on 2025-07-18
Most Supportive Themes
- $CRNX Positive Outlook: (75%) Positive sentiment around $CRNX and its potential to be a game changer in endocrine treatments.
- Palsonify Excitement: (25%) Enthusiasm for Palsonify (paltusotine) and its potential impact on acromegaly treatment.
Most Critical Themes
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XX | X% | X | X% |
| Total | XXX | XX% | XX | X% | X | X% |
Top assets mentioned In the posts about $ipsey in the last XX hours
Novartis AG (NVS) Eli Lilly and Company (LLY) Verisk Analytics, Inc. (VRSK) Tyler Technologies, Inc. (TYL)
Top topics mentioned In the posts about $ipsey in the last XX hours
drugs, $nvs, hc, lun, arx, thc, bax, teva, 100m, $lly, $2012m, $phvs, ole, longterm, $bchmy, googl, bdx, $bimpa, $sgopa, $gloppa, $xers, tei, flc, $vrsk, $tyl, $tiog
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"📌 Biotech Stock News 7/25 @ Open 🔔 $LYEL XX% $100M Equity Placement $NXTC XX% Anti-Siglec-15 Treatment Data Update $OMER X% Pricing of $22M Offering $GILD X% Lenacapavir +CHMP Opinion $IPSEY X% Cabometyx EU Approval $EXEL X% CABOMETYX EU Approval $PHVS X% Closing of $201.2M Offering $INCY X% Initial Data for Bispecific Antibody $LLY X% Positive opinion for Alzheimers treatment $ELAN X% Approval of Innovative Canine Tx $BNTX X% COVID-19 Vaccine +CHMP Opinion $KRYS X% VYJUVEK Approval for DEB $MRNA X% Positive Opinion for COVID-19 Vaccine $IONS -X% Recommended for approval in EU $BIIB -1%"
@BiopharmIQ on X 2025-07-25 15:51:31 UTC 25.8K followers, 3623 engagements
"Piper Sandler y'day reit'd $CRNX OW-$97-Top Pick after🗣w/ a Leading ENDOhe Tx's a couple hundred acromegaly ptsplans to offer PALSONIFY immediately to almost all pts +was impressed w/ atumelnant's Ph1b/2a Cushing's data/is +VE on this opp $BCHMY $IPSEY $NVS $CORT $XERS Piper Sandler in its note to investors said:"
@Quantumup1 on X 2025-07-22 18:41:19 UTC 3534 followers, 1909 engagements
"$CRNX (L) have been adding since it dropped into the $30s think paltusotine would be a game changer for patients prev relied on injections or twice daily oral drug before. Undisputed leader in endocrine"
@streamtailvents on X 2025-07-22 10:35:27 UTC XX followers, XXX engagements
"H.C. Wainwright reiterated $CRNX Buy-$81 and said "At the #ENDO 2025 conference we felt strong enthusiasm towards Palsonify (paltusotine) from many expert endocrinologists." $BCHMY $IPSEY $NVS #ENDO2025 H.C. Wainwright added "They were all excited about the drug's compelling efficacy and durability on top of a convenient once-daily dosing regimen. Many called it a "game changer" in acromegaly compared to the current standard-of-care whether intramuscular somatostatin receptor ligands (SRL) injections or twice-daily oral SRLs. Unlike the injectables paltusotine has been shown to provide"
@Quantumup1 on X 2025-07-21 17:37:06 UTC 3534 followers, 4045 engagements